Drugs / BAY60-4552
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01110590 | Jan → Apr 2010 | erectile dysfunction | Bayer | Completed | No outcome recorded |
| Phase 1 | NCT00565565 | Oct 2007 → Dec 2008 | heart failure | Bayer | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01168817 | Aug 2010 → May 2011 | erectile dysfunction | Bayer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY60-4552 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01110590 ↗ |
| Route | Oral | “single oral dose of BAY60-4552” NCT00565565 ↗ |